ArticleOncotarget2016

Targeting hyperactivated DNA-PKcs by KU0060648 inhibits glioma progression and enhances temozolomide therapy via suppression of AKT signaling.

Tian Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.